ABIOMED is headquartered in Danvers, US
ABIOMED Office Locations
ABIOMED has offices in Danvers and Aachen
Danvers, US (HQ)
22 Cherry Hill Dr
Aachen, DE
3 Neuenhofer Weg
ABIOMED Data and Metrics
ABIOMED Financial Metrics
ABIOMED's revenue was reported to be $329.5 m in 2016
USD
Revenue (Y, 2016) | 329.5 m |
Revenue growth (Y, 2015 - Y, 2016), % | 43% |
Net income (Y, 2016) | 38.1 m |
EBIT (Y, 2016) | 65.1 m |
Market capitalization (28-Jun-2017) | 6.2 b |
Closing share price (28-Jun-2017) | 140.5 |
Cash (31-Mar-2016) | 48.2 m |
ABIOMED's current market capitalization is $6.2 b.
| USD | FY, 2014 | FY, 2015 | Y, 2016 |
|---|---|---|---|
Revenue | 183.6 m | 230.3 m | 329.5 m |
Revenue growth, % | 25% | 43% | |
Gross profit | 146.3 m | 190.4 m | |
Gross profit Margin, % | 80% | 83% | |
Operating expense total | 138 m | 161.7 m | 264.4 m |
EBIT | 8.4 m | 28.7 m | 65.1 m |
EBIT margin, % | 5% | 12% | 20% |
Pre tax profit | 8.5 m | 28.8 m | 65.8 m |
Income tax expense | 1.2 m | (84.9 m) | 27.7 m |
Net Income | 7.4 m | 113.7 m | 38.1 m |
| USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Cash | 20.9 m | 22.4 m | 48.2 m |
Accounts Receivable | 24.4 m | 31.8 m | 42.8 m |
Inventories | 13.9 m | 16.8 m | 26.7 m |
Current Assets | 118 m | 220.1 m | 288.4 m |
PP&E | 6.9 m | 9.1 m | 23.2 m |
Goodwill | 38 m | 31.5 m | 33 m |
Total Assets | 205.4 m | 338.4 m | 423.9 m |
Accounts Payable | 7.7 m | 10.4 m | 9.4 m |
Current Liabilities | 30.4 m | 39.3 m | 46.5 m |
Additional Paid-in Capital | 436.1 m | 465 m | 508.6 m |
Retained Earnings | (250.9 m) | (137.2 m) | (99.1 m) |
Total Equity | 168.4 m | 291.6 m | 368.8 m |
Financial Leverage | 1.2 x | 1.2 x | 1.1 x |
| USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Net Income | 7.4 m | 113.7 m | 38.1 m |
Depreciation and Amortization | 2.8 m | 3.3 m | |
Accounts Receivable | (1.3 m) | (8 m) | (11 m) |
Inventories | (622 k) | (7 m) | (11 m) |
Accounts Payable | (54 k) | 3.4 m | (2.6 m) |
Cash From Operating Activities | 23.5 m | 43.3 m | 76.8 m |
Purchases of PP&E | (2.8 m) | (5.2 m) | (15.6 m) |
Cash From Investing Activities | (22.3 m) | (49.9 m) | (57.7 m) |
Cash From Financing Activities | 9.6 m | 9.5 m | 7.2 m |
Income Taxes Paid | 1.3 m | 1.2 m | 848 k |
| Y, 2016 | |
|---|---|
Financial Leverage | 1.1 x |
ABIOMED Market Value History
ABIOMED Median Salaries
Source: 15 public H-1B filings from ABIOMED
